Fibromyalgia is a chronic condition that causes widespread pain, fatigue, and other symptoms. It affects about 2% of the population, mostly women, and can have a significant impact on quality of life. The exact cause of fibromyalgia is unknown, but it is thought to involve abnormal pain processing in the nervous system [1].
One of the possible factors involved in fibromyalgia pain is TRPV, or transient receptor potential vanilloid. TRPV is a family of ion channels that are expressed in sensory neurons and other tissues. They are activated by various stimuli, such as heat, acidity, and chemical compounds. Some of these compounds are found in spicy foods, such as capsaicin, the active ingredient in chili peppers [2].
TRPV channels play a role in pain perception and inflammation. They can modulate the activity of other pain receptors, such as opioid receptors, and influence the release of neurotransmitters, such as substance P and calcitonin gene-related peptide (CGRP). These neurotransmitters are involved in transmitting pain signals from the peripheral nerves to the spinal cord and brain [3].
Some studies have suggested that TRPV channels may be dysregulated in fibromyalgia patients. For example, one study found that fibromyalgia patients had higher levels of TRPV1 expression in their skin biopsies than healthy controls [4]. Another study found that fibromyalgia patients had lower levels of TRPV4 expression in their blood cells than healthy controls [5].
The implications of these findings are not clear yet, but they may indicate that TRPV channels are involved in the pathophysiology of fibromyalgia. They may also offer potential targets for new treatments. For example, some drugs that block or activate TRPV channels have been shown to have analgesic effects in animal models and human trials. These drugs include capsaicin creams, resiniferatoxin injections, and olvanil capsules [6].
However, more research is needed to confirm the role of TRPV channels in fibromyalgia and to evaluate the safety and efficacy of TRPV modulators for fibromyalgia patients. Until then, patients should consult their doctors before trying any new treatments or supplements that may affect TRPV channels.
Search the Blog! #fibromyalgia
References:
[1] Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014 Apr 16;311(15):1547-55.
[2] Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997 Oct 23;389(6653):816-24.
[3] Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007 May;6(5):357-72.
[4] Kim SH, Kim DH, Oh DH et al. Increased expression of N-methyl-D-aspartate receptor subunit 2D in the skin of patients with fibromyalgia. Rheumatology (Oxford). 2015 Jun;54(6):1068-76.
[5] Kim DH, Kim SH et al. Decreased expression of transient receptor potential vanilloid 4 in the dorsal root ganglion and skin biopsies from patients with fibromyalgia syndrome. Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 116(5):S27-S33.
[6] Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011 Oct;107(4):490-502.

Comments
Post a Comment